Further Update on Funding
Cellbxhealth PLC (AIM:CLBX) announced on 5 November 2025 a further update on its funding, revealing a current cash runway extending only into early 2026. The company is actively seeking to raise approximately £6 million through discussions with shareholders, intending to conduct an offer to retail investors concurrently with an institutional placing. This crucial fundraise, expected to be announced by early December, is vital for the company's continued operations and could significantly impact its stock share price due to potential dilution for existing shareholders.
Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes
CELLBXHEALTH plc (AIM:CLBX), a global leader in circulating tumour cell (CTC) intelligence, announces, further to the interim results of 9 October 2025, the Company currently has a cash runway into early 2026. CelLBxHealth has recently commenced discussions with a number of shareholders and is seeking to raise approximately £6m with the intention to make an offer to retail investors alongside an institutional placing.
The Company expects to announce the fundraise by early December and will make further updates as appropriate.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.